Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 52, pages 183–190 (2017)Cite this article

Subjects

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for many patients with severe benign and malignant hematologic disorders. The success of allogeneic HSCT is limited by the development of transplant-related complications such as acute graft-versus-host disease (GvHD). Early pre-clinical studies suggested that intestinal microflora contribute to the pathogenesis of acute GvHD, and that growth suppression or eradication of intestinal bacteria prevented the development of acute GvHD even in MHC-mismatched transplants. These observations led to the practice of gut decontamination (GD) with oral non-absorbable antibiotics in patients undergoing allogeneic HSCT as a method of acute GvHD prophylaxis. Microbiome studies in the modern sequencing era are beginning to challenge the benefit of this practice. In this review, we provide a historical perspective on the practice of GD and highlight findings from the limited number of clinical trials evaluating the use of GD for acute GvHD prevention in allogeneic HSCT patients. In addition, we examine the role of the gut microbiota in allogeneic HSCT in the context of recent studies linking the microflora to regulation of intestinal immune homeostasis. We discuss the implications of these findings for future strategies to reduce acute GvHD risk by selective manipulation of the microbiota.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH et al. Prospective evaluation of 2 acute graft-versus-host (GvHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005; 106: 1495–1500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Blazar BR, Murphy WJ, Abedi M . Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443–458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55: 905–914.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jenq R, Taur Y, Devlin S, Ponce D, Goldberg J, Ahr KF et al. Intestinal blautia is associated with reduced geath from graft-versus-host disease. Biol Blood Marrow Transplant 2015; 21: 1373–1383.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jones JM, Wilson R, Bealmear PM . Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971; 45: 577–588.

    Article  CAS  PubMed  Google Scholar 

  7. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D . Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52: 401–404.

    Article  CAS  PubMed  Google Scholar 

  8. Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992; 175: 405–413.

    Article  CAS  PubMed  Google Scholar 

  9. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE . Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J Immunol 1994; 152: 1004–1013.

    CAS  PubMed  Google Scholar 

  10. Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT et al. Protective environment for marrow transplant recipients: a prospective study. Ann Int Med 1978; 89: 893–901.

    Article  CAS  PubMed  Google Scholar 

  11. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983; 308: 302–307.

    Article  CAS  PubMed  Google Scholar 

  12. Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJ, Hermans J, Dooren LJ . Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990; 9: 14–23.

    Article  CAS  PubMed  Google Scholar 

  13. Vossen JM, Guiot HF, Lankester AC, Vossen AC, Bredius RG, Wolterbeek R et al. Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation. PLoS ONE 2014; 9: e105706.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Beelen DW, Haralambie E, Brandt H, Linzenmeier G, Muller KD, Quabeck K et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992; 80: 2668–2676.

    CAS  PubMed  Google Scholar 

  15. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW . Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999; 93: 3267–3275.

    CAS  PubMed  Google Scholar 

  16. Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2014; 20: 640–645.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kersun LS, Propert KJ, Lautenbach E, Bunin N, Demichele A . Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatr Blood Cancer 2005; 45: 162–169.

    Article  PubMed  Google Scholar 

  18. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359–2364.

    Article  CAS  PubMed  Google Scholar 

  20. Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN . Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000; 118: 1094–1105.

    Article  CAS  PubMed  Google Scholar 

  21. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001; 69: 2277–2285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Cong Y, Brandwein SL, McCabe RP, Lazenby A, Birkenmeier EH, Sundberg JP et al. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp med 1998; 187: 855–864.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485–498.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31: 677–689.

    Article  CAS  PubMed  Google Scholar 

  25. Strauch UG, Obermeier F, Grunwald N, Gurster S, Dunger N, Schultz M et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 2005; 54: 1546–1552.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL . Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5: 1461–1471.

    Article  CAS  PubMed  Google Scholar 

  27. Round JL, Mazmanian SK . Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107: 12204–12209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL . An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107–118.

    Article  CAS  PubMed  Google Scholar 

  29. Mazmanian SK, Round JL, Kasper DL . A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620–625.

    Article  CAS  PubMed  Google Scholar 

  30. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337–341.

    Article  CAS  PubMed  Google Scholar 

  31. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232–236.

    Article  CAS  PubMed  Google Scholar 

  32. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–573.

    Article  CAS  PubMed  Google Scholar 

  33. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451–455.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446–450.

    Article  CAS  PubMed  Google Scholar 

  35. Ohnmacht C, Park JH, Cording S, Wing JB, Atarashi K, Obata Y et al. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 2015; 349: 989–993.

    Article  CAS  PubMed  Google Scholar 

  36. Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 2015; 349: 993–997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Schiering C, Krausgruber T, Chomka A, Frohlich A, Adelmann K, Wohlfert EA et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513: 564–568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cebula A, Seweryn M, Rempala GA, Pabla SS, McIndoe RA, Denning TL et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013; 497: 258–262.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Morton AM, Sefik E, Upadhyay R, Weissleder R, Benoist C, Mathis D . Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc Natl Acad Sci USA 2014; 111: 6696–6701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Weisburg WG, Barns SM, Pelletier DA, Lane DJ . 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991; 173: 697–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Vetrovsky T, Baldrian P . The variability of the 16 S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS ONE 2013; 8: e57923.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Tringe SG, von Mering C, Kobayashi A, Salamov AA, Chen K, Chang HW et al. Comparative metagenomics of microbial communities. Science 2005; 308: 554–557.

    Article  CAS  PubMed  Google Scholar 

  43. Tyson GW, Chapman J, Hugenholtz P, Allen EE, Ram RJ, Richardson PM et al. Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 2004; 428: 37–43.

    Article  CAS  PubMed  Google Scholar 

  44. Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124: 1174–1182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342: 967–970.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342: 971–976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M et al. Cancer and the gut microbiota: an unexpected link. Sci Transl Med 2015; 7: 271ps1.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Balmer ML, Schurch CM, Saito Y, Geuking MB, Li H, Cuenca M et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J Immunol 2014; 193: 5273–5283.

    Article  CAS  PubMed  Google Scholar 

  49. Buffie CG, Pamer EG . Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 13: 790–801.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012; 149: 1578–1593.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012; 209: 903–911.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Khosravi A, Yanez A, Price JG, Chow A, Merad M, Goodridge HS et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014; 15: 374–381.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55–60.

    Article  CAS  PubMed  Google Scholar 

  54. Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR . Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015; 101: 428–437.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159–166.

    Article  CAS  PubMed  Google Scholar 

  56. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013; 5: 193ra91.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Joice R, Yasuda K, Shafquat A, Morgan XC, Huttenhower C . Determining microbial products and identifying molecular targets in the human microbiome. Cell Metab 2014; 20: 731–741.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Bikel S, Valdez-Lara A, Cornejo-Granados F, Rico K, Canizales-Quinteros S, Soberon X et al. Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput Struct Biotechnol J 2015; 13: 390–401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Cho I, Blaser MJ . The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13: 260–270.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Hegazy AN, Powrie F . MICROBIOME. Microbiota RORgulates intestinal suppressor T cells. Science 2015; 349: 929–930.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA and Harvard Medical School, Boston, MA, USA

    J Whangbo & J Ritz

  2. Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA and Harvard Medical School, Boston, MA, USA

    J Whangbo

  3. Department of Medicine and Department of Genetics, Stanford University, Stanford, CA, USA

    A Bhatt

Authors
  1. J Whangbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Ritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Bhatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Bhatt.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whangbo, J., Ritz, J. & Bhatt, A. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52, 183–190 (2017). https://doi.org/10.1038/bmt.2016.206

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.206

This article is cited by

Search

Advanced search

Quick links